MedTrace Logo

Evaluation of Laser and Tranexamic Acid in Treatment of Melasma

NCT04599205 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-10-22

No results posted yet for this study

Summary

Melasma Is an acquired, chronic, recurrent, symmetrical hypermelanosis, which is characterized by brown patches of variable darkness on sun exposed areas of the body. It is more common in women. It is common psychologically and emotionally distressing cosmetic problem in affected patients .

Conditions

  • Melasma

Interventions

DRUG

Tranexamic acid

fractional co2 laser, microneedling and topical tranexamic acid gel

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • EMAN R MOHAMED, MD · assuit university hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-31
Primary Completion
2021-12-31
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04599205 on ClinicalTrials.gov